Certara Announces Pricing of its Upsized Initial Public Offering
PRINCETON, NJ.— 2020年12月10日 – Certara, Inc. (“Certara”), a global leader in biosimulation, today…
Certara2020年12月10日
Certara’s Phoenix software supports training of the next generation of the pharmacometricians in China
The Pharmacy department of the Shanghai Chest Hospital is dedicated to developing and applying model-informed…
Certara2020年12月3日
Mechanistic model-informed discovery & development of bispecific antibodies for immuno-oncology: It takes 2 to tango
More than 50 bispecific antibodies are in oncology clinical development with a large diversity in…
Certara2020年12月2日
Getting Real with RWE
By Taren Grom Real-world evidence, important for regulatory decision-making, is beginning to touch all areas…
Certara2020年11月20日
Regulatory submissions and transactions with Health Canada
By Robert Labriola We’ve seen recent trends and activity with regards to pharmaceutical regulatory submissions…
Certara2020年11月19日
How PBPK Modeling Can Replace Drug-Drug Interaction Studies
Patients often take more than one drug at a time, especially elderly patients and those…
Certara2020年11月12日
Certara Opens New China Office in Shanghai
Office will support rapid growth and collaboration with customers in China to accelerate biopharmaceutical R&D …
Certara2020年11月9日
